erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
'i mean all she pretty much did was spread the word and reach out to her baby daddies, so she felt like, "that's how i helped, " continued the insider, referring to ex
.
.
.
copyright 2018 npr. to see more, visit /www.npr.org/.
.